OVID(Ovid Therapeutics Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $208.38M | $1.50M | $392.00K | $566.00K | $7.25M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $124.21M | −$55.55M | −$59.28M | −$61.88M | −$42.44M |
| 净利润 | $122.83M | −$54.17M | −$52.34M | −$26.43M | −$17.41M |
| 经营现金流 | $118.61M | −$55.23M | −$45.78M | −$55.96M | −$38.33M |
| 自由现金流 | $118.43M | −$56.45M | −$45.82M | −$56.03M | −$38.33M |
| 摊薄每股收益 | $1.76 | $-0.77 | $-0.74 | — | — |